Heuristic for Two-Level Cache Hierarchy Exploration Considering Energy Consumption and Performance

A. Silva-Filho,F. Cordeiro,R. E. Sant'Anna,M. Lima

DOI: https://doi.org/10.1007/11847083_8

2006-09-13

Abstract:

What problem does this paper attempt to address?

A Chitosan/gelatin/aldehyde Hyaluronic Acid Hydrogel Coating Releasing Calcium Ions and Vancomycin in Ph Response to Prevent the Formation of Bacterial Biofilm

Yuange Li,Hong Sung Min,Chen,Haojie Shan,Yiwei Lin,Fuli Yin,Yixian Chen,Liheng Lu,Xiaowei Yu

DOI: https://doi.org/10.1016/j.carbpol.2024.122723

IF: 10.723

2025-01-01

Carbohydrate Polymers

Abstract:Osteomyelitis is a refractory disease of orthopedics, part of which is caused by medical implants. The main difficulties in treatment are the barrier effect after the formation of bacterial biofilm, and the difficulty in achieving sustained antibiotic intervention. In view of this situation, we studied a hydrogel coating that can release CaCl2 and vancomycin in pH-responsive manner. We used nano-TiO2 to modify Chitosan/ Gelatin/Aldehyde Hyaluronic Acid (CS/Gel/AHA) hydrogel, and combined with the dip-coating technique, prepared a coating with good mechanical strength. The hydrogel-loaded zeolitic imidazolate framework (ZIF) decomposes under acidic conditions, and the released Ca2+ act on the bacterial Bap protein to inhibit the formation of biofilm, and the released vancomycin kills free bacteria. The antibacterial coating achieved good bactericidal effect in both in vitro experiments and rat subcutaneous implant model. These results not only provide a new way to enhance the strength of hydrogels to prepare coatings, but also utilize a new approach to responsively inhibit the formation of biofilms, showing the promising application prospects of the coating in antibacterial treatment of medical implants.
An injectable magnesium-coordinated phosphate chitosan-based hydrogel loaded with vancomycin for antibacterial and osteogenesis in the treatment of osteomyelitis

Peng Zhang,Tiehua Wang,Junyu Qian,Haotian Qin,Peng Liu,Ao Xiong,Anjaneyulu Udduttula,Deli Wang,Hui Zeng,Yingqi Chen

DOI: https://doi.org/10.1093/rb/rbae049

2024-05-25

Abstract:Microbial infections of bones, particularly after joint replacement surgery, are a common occurrence in clinical settings and often lead to osteomyelitis (OM). Unfortunately, current treatment approaches for OM are not satisfactory. To address this issue, this study focuses on the development and evaluation of an injectable magnesium oxide (MgO) nanoparticle (NP)-coordinated phosphocreatine-grafted chitosan hydrogel (CMPMg-VCM) loaded with varying amounts of vancomycin (VCM) for the treatment of OM. The results demonstrate that the loading of VCM does not affect the formation of the injectable hydrogel, and the MgO-incorporated hydrogel exhibits anti-swelling properties. The release of VCM from the hydrogel effectively kills S.aureus bacteria, with CMPMg-VCM (50) showing the highest antibacterial activity even after prolonged immersion in PBS solution for 12 days. Importantly, all the hydrogels are non-toxic to MC3T3-E1 cells and promote osteogenic differentiation through the early secretion of alkaline phosphatase and calcium nodule formation. Furthermore, in vivo experiments using a rat OM model reveal that the CMPMg-VCM hydrogel effectively kills and inhibits bacterial growth, while also protecting the infected bone from osteolysis. These beneficial properties are attributed to the burst release of VCM, which disrupts bacterial biofilm, as well as the release of Mg ions and hydroxyl by the degradation of MgO NPs, which inhibits bacterial growth and prevents osteolysis. Overall, the CMPMg-VCM hydrogel exhibits promising potential for the treatment of microbial bone infections.
In situ formed antibacterial hydrogel with collagenase-responsive activity for prevention of MRSA-induced osteomyelitis

Kejia Li,Xiaoyan Ju,Xiangli Li,Guojun Lu,Jinzhao Ou,Dandan Xu,Chenxiao Wan,Meng Zhu,Chuanchao Du,Ye Tian,Zhongwei Niu

DOI: https://doi.org/10.1016/j.cej.2024.151475

IF: 15.1

2024-04-25

Chemical Engineering Journal

Abstract:Osteomyelitis caused by methicillin-resistant Staphylococcus aureus (MRSA) is a challenging and life-threatening disease due to its long duration and deep site of occurrence. Herein, we design an in situ formed antibacterial hydrogel with collagenase-respontive activity for the prevention of MRSA-induced osteomyelitis. This hydrogel is constructed by chemical bonding between a 4-arm polyethylene glycol maleimide (4-Arm-PEG-Mal), an N-terminal maleimidated antimicrobial peptide (Mal-AMP) and a collagenase-cleavable peptide with two thiol groups (HS-VPM-SH). Collagenase-induced hydrogel cleavage confers on-demand delivery of the antimicrobial peptide, thereby enhancing the combating activity against MRSA in an infected environment. The designed hydrogel, namely AMP/VPM/PEG hydrogel, can be formed rapidly in situ under physiological conditions due to the rapid bonding between the maleimide and thiol groups. In the in vivo rat osteomyelitis model, the AMP/VPM/PEG hydrogel can be administered by simply injecting the 4-Arm-PEG-Mal and peptide solutions with a 26G needle, which is a minimally invasive method. In vivo evaluation further demonstrates that AMP/VPM/PEG hydrogel can successfully prevent MRSA-induced osteomyelitis. This work provides a minimally invasive approach for intramedullary delivery of antimicrobial peptides on-demand and may provide a viable strategy for the osteomyelitis prevention in clinic.

engineering, chemical, environmental
Multifunctional Injectable Microspheres Containing "Naturally-Derived" Photothermal Transducer for Synergistic Physical and Chemical Treating of Acute Osteomyelitis through Sequential Immunomodulation.

Guo Chen,Liqiong Liao,Yang Shen,Bin Chen,Ziqian Yu,Yaowen Xu

DOI: https://doi.org/10.1021/acsnano.3c10697

IF: 17.1

2024-02-09

ACS Nano

Abstract:Osteomyelitis induced by Staphylococcus aureus (S. aureus) is a persistent and deep-seated infection that affects bone tissue. The main challenges in treating osteomyelitis include antibiotic resistance, systemic toxicity, and the need for multiple recurrent surgeries. An ideal therapeutic strategy involves the development of materials that combine physical, chemical, and immunomodulatory synergistic effects. In this work, we prepared injectable microspheres consisting of an interpenetrating network of ionic-cross-linked sodium alginate (SA) and genipin (Gp)-cross-linked gelatin (Gel) incorporated with tannic acid (TA) and copper ions (Cu2+). The Gp-cross-linked Gel acted as a "naturally-derived" photothermal therapy (PTT) agent. The results showed that the microspheres exhibited efficient and rapid bactericidal effects against both S. aureus and Escherichia coli (E. coli) under the irradiation of near-infrared light at 808 nm wavelength; moreover, the release of Cu2+ also induced sustained inhibitory effects against bacteria during the nonirradiation period. The in vitro cell culture results indicated that when combined with PTT, the microspheres could adaptively modulate macrophage M1 and M2 phenotypes in sequence. Additionally, these microspheres were found to enhance the osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs). In vivo studies conducted in a rat femur osteomyelitis model with bone defects showed that under multiple laser irradiation the microspheres effectively controlled bacterial infection, improved the pathological immune microenvironment, and significantly enhanced the repair and regeneration of bone tissues in the affected area.

Engineering,Medicine,Materials Science
Preparation of fish collagen and vancomycin microspheres based on microfluidic technology and its application in osteomyelitis

Xiaowu Hu,Jinshan Tang,Huaixi Yu,Hanshi Yang,Xiaoqing Lu,Donghui Zheng

DOI: https://doi.org/10.3389/fbioe.2023.1249706

IF: 5.7

2023-10-17

Frontiers in Bioengineering and Biotechnology

Abstract:At present, the clinical treatment of osteomyelitis and osteomyelitis-induced bone defects is challenging, easy to recur, drug toxic side effects, secondary or multiple surgeries, etc. The design of biodegradable composite biomaterials to improve antibiotics in the local precise anti-infection at the same time to complete the repair of bone defects is the current research hot spot. Herein, a composite hydrogel with a double bond at the end (FA-MA) was prepared by affinity addition reaction between fish collagen (FA) and methacrylic anhydride (MA) under photoinitiator initiation conditions, then, FA-MA was amino-activated by EDC/NHC, and vancomycin was attached to FA-MA via amide bonding to prepare FA-MA-Van hydrogels, and finally, the composite hydrogel microspheres were prepared by microfluidic technology. The structure of the hydrogel was confirmed by SEM (elemental analysis), optical microscopy, FTIR, and XPS to confirm the successful preparation. The composite hydrogel microspheres showed the better antimicrobial effect of hydrogel microspheres by bacterial coated plate experiments and SEM morphology results, with the antimicrobial class reaching 99.8%. The results of immunofluorescence staining and X-ray experiments showed that the hydrogel microspheres had a better effect on promoting bone repair. This engineered design of hydrogel microspheres provides clinical significance for treating osteomyelitis at a later stage.

multidisciplinary sciences
Vancomycin-loaded silk fibroin microspheres in an injectable hydrogel for chronic osteomyelitis therapy

Peng Zhang,Yusheng Sun,Haizhen Yang,Dong Liu,Feng Zhang,Yu Zhang,Wentao Zhong,Baoqi Zuo,Zhiqiang Zhou

DOI: https://doi.org/10.3389/fbioe.2023.1163933

IF: 5.7

2023-06-01

Frontiers in Bioengineering and Biotechnology

Abstract:Introduction: Chronic osteomyelitis remains a clinical challenge in orthopedics. Methods: In this study, silk fibroin microspheres (SFMPs) loaded with vancomycin are entrapped in an injectable silk hydrogel to form a vancomycin delivery system for treatment of chronic osteomyelitis. Results and Discussion: Vancomycin showed continuous release from the hydrogel for up to 25 days. The hydrogel shows strong antibacterial activity against both Escherichia coli and Staphylococcus aureus and a long antibacterial duration of 10 days without a decrease in the antibacterial effect. The injection of vancomycin-loaded silk fibroin microspheres entrapped in the hydrogel into the infected site of rat tibia reduced bone infection and improved bone regeneration compared with other treatment groups. Conclusion: Thus, the composite SF hydrogel features a sustained-release profile and good biocompatibility, making it promising for application in osteomyelitis treatment.

multidisciplinary sciences
Injectable Chitosan-Based Thermosensitive Hydrogel/Nanoparticle-Loaded System for Local Delivery of Vancomycin in the Treatment of Osteomyelitis

Jin Tao,Yang Zhang,Ao Shen,Yunxu Yang,Lu Diao,Luye Wang,Danwei Cai,Ying Hu

DOI: https://doi.org/10.2147/ijn.s247088

IF: 7.033

2020-08-01

International Journal of Nanomedicine

Abstract:PURPOSE: Osteomyelitis, particularly chronic osteomyelitis, remains a major challenge for orthopedic surgeons. The traditional treatment for osteomyelitis, which involves antibiotics and debridement, does not provide a complete solution for infection and bone repair. Antibiotics such as vancomycin (VCM) are commonly used to treat osteomyelitis in clinical settings. VCM use is limited by a lack of effective delivery methods that provide sustained, high doses to entirely fill irregular bone tissue to treat infections.METHODS: We engineered a chitosan (CS)-based thermosensitive hydrogel to produce a VCM-nanoparticle (NPs)/Gel local drug delivery system. The VCM-NPs were formed with quaternary ammonium chitosan and carboxylated chitosan nanoparticles (VCM-NPs) by positive and negative charge adsorption to enhance the encapsulation efficiency and drug loading of VCM, with the aim of simultaneously preventing infection and repairing broken bones. This hydrogel was evaluated in a rabbit osteomyelitis model.RESULTS: The VCM-NPs had high encapsulation efficiency and drug loading, with values of 60.1±2.1% and 24.1±0.84%, respectively. When embedded in CS-Gel, the VCM-NPs maintained their particle size and morphology, and the injectability and thermosensitivity of the hydrogel, which were evaluated by injectability test and rheological measurement, were retained. The VCM-NPs/Gel exhibited sustained release of VCM over 26 days. In vitro tests revealed that the VCM-NPs/Gel promoted osteoblast proliferation and activity against <i>Staphylococcus aureus</i>. In vivo, VCM-NPs/Gel (with 10 mg vancomycin per rabbit) was used to treat rabbits with osteomyelitis. The VCM-NPs/Gel showed excellent anti-infection properties and accelerating bone repair under osteomyelitis conditions.CONCLUSION: The reported multifunctional NPs hydrogel system for local antibiotic delivery (VCM-NPs/Gel) showed bone regeneration promotion and anti-infection properties, demonstrating significant potential as a scaffold for effective treatment of osteomyelitis.

pharmacology & pharmacy,nanoscience & nanotechnology
Injectable rBMSCs-laden hydrogel microspheres loaded with naringin for osteomyelitis treatment

Minyi Dong,Xiaofu Yang,Jingyi Lu,Lixuen Siow,Huihui He,An Liu,Pengcheng Wu,Yong He,Miao Sun,Mengfei Yu,Huiming Wang,Mingyi Dong

DOI: https://doi.org/10.1088/1758-5090/aceaaf

2023-07-28

Biofabrication

Abstract:Osteomyelitis, caused by purulent bacteria invading bone tissue, often occurs in long bones and seriously affects the physical and mental health and working ability of patients, and even endangers life. However, due to its cavity structure, osteomyelitis tends to occur inside the bone and lacks an effective treatment, which needs anti-inflammatory and repair of bone defects. Here, we developed an injectable hydrogel micro microspheres loaded with naringin and bone marrow mesenchymal stem cells (BMSCs), which are not only anti-inflammatory; but also osteogenic. These homogeneous microspheres are rapidly fabricated by the electro-assisted bioprinting method, with sizes from 200 to 1000 μm. Interestingly, it was found that microspheres with relatively small diameters (200 μm) were more conducive to the initial cell attachment, growth, spread, and later osteogenic differentiation. It can achieve an effective treatment for tibial osteomyelitis in rats within six weeks, proving that it has a positive prospect for clinical application.

engineering, biomedical,materials science, biomaterials
Silk fibroin/chitosan thiourea hydrogel scaffold with vancomycin and quercetin-loaded PLGA nanoparticles for treating chronic MRSA osteomyelitis in rats

Majid Jafarbeglou,Abdolhamid Meimandi-Parizi,Abdollah Derakhshandeh,Azizollah Khodakaram-Tafti,Amin Bigham-Sadegh,Pouya Arkan,Maryam Jafarbeglou

DOI: https://doi.org/10.1016/j.ijpharm.2024.124826

2024-10-12

Abstract:Chronic osteomyelitis presents significant treatment challenges, necessitating an efficient system for infection elimination and bone repair. This study developed a natural hydrogel scaffold using silk fibroin (SF) and chitosan thiourea (CST), incorporating vancomycin (VC) and quercetin (QC) loaded PLGA nanoparticles (NPs) for dual-purpose treatment. SF/CST hydrogel scaffolds exhibited homogeneous porosity and smaller interconnected pore size than pure SF and pure CST hydrogel scaffolds. Optimal PLGA/QC NPs measured 206 nm in size, displayed spherical morphology, had uniform distribution, and achieved 87 % QC loading. The release study showed sustained long-term release of VC and QC from the hydrogel scaffolds for over 20 days. Biocompatibility tests indicated that hydrogel scaffolds promoted osteoblast adhesion without cytotoxicity, with QC-containing scaffolds enhancing osteoblast growth. Antibacterial tests confirmed retained VC activity against methicillin-resistant Staphylococcus aureus (MRSA) in SF/CST. An experimental study assessed the efficacy of the hydrogel scaffolds in a MRSA-infected rat osteomyelitis model. Radiographic scores demonstrated a significant reduction for SF/CST-VC-PLGA/QC NPs compared to control, indicating reduced osteomyelitis effects. Macroscopic evaluations showed notable reductions in gross pathological effects for VC-containing groups. Histopathological assessments revealed significantly lower osteomyelitis scores and higher healing scores in the SF/CST-VC-PLGA/QC NPs, with reduced inflammatory cell infiltration and more organized connective tissue formation. In conclusion, SF/CST-VC-PLGA/QC NPs is an effective dual drug delivery system for osteomyelitis treatment, demonstrating significant antibacterial activity, enhanced bone regeneration, and reduced infection rate.
An injectable carboxymethyl chitosan hydrogel scaffold formed via coordination bond for antibacterial and osteogenesis in osteomyelitis

Tianyi Zhou,Haiyan Zhou,Fei Wang,Peng Zhang,Jian Shang,Leilei Shi

DOI: https://doi.org/10.1016/j.carbpol.2023.121466

IF: 10.723

2023-10-12

Carbohydrate Polymers

Abstract:The intricate, hostile, and diverse nature of osteomyelitis (OM) poses a challenge for complete bacterial eradication and osteogenesis promotion via conventional treatment. Recently, functional hydrogels exhibiting antibacterial and osteogenic properties emerge as a promising avenue for OM wound healing in clinical practice. However, the preparation procedures and associated costs on cytokine and cell therapies for certain functional hydrogels can be complex and prohibitively expensive. In our research, a hybrid hydrogel dressing has been formulated utilizing carboxymethyl chitosan (CMCS) as the base material, and designed with inherent antibacterial, adhesion, proliferation, and differentiation characteristics, showing promise as a candidate for eradicating infection and promoting bone regeneration. The hybrid hydrogel is composed of interconnected networks of Fe 3+ -induced self-assembled CMCS and the antibacterial drug ciprofloxacin (CIP), resulting in excellent injectability and moldability. Notably, the CMCS/Fe 3+ /CIP hybrid hydrogel is capable of regulating antibacterial responses and stimulating osteogenesis in infected microenvironments without additional additives. This injectable antibacterial and osteogenic-promoting hydrogel establish a high-potential platform for low-cost, safe and effective treatment of OM by expediting the initial stages of infected bone wound repair.

polymer science,chemistry, organic, applied
What can RSS point out in accounts receivable?

S. Allcorn,J. Glenn

1985-03-01

Abstract:Either periodic appraisal or an unusual event may cause a medical group manager to analyze the group's accounts receivable system. Retrospective selective sampling (RSS) is an analysis method which tracks previously posted charges through the accounts receivable system step by step. The authors examine how the manager can make a selective sampling of charges, track those charges through the system, and interpret the RSS analysis.
An Andrias davidianus derived composite hydrogel with enhanced antibacterial and bone repair properties for osteomyelitis treatment

Chong Yin,Meng Deng,Jinshu Yu,Yonghao Chen,Kaiyuan Zheng,Yi Huang,Xudong Deng,Ye Tian,Yuwen Ma,Beilei Zeng,Xiaolan Guo,Bin Guo

DOI: https://doi.org/10.1038/s41598-024-75997-8

IF: 4.6

2024-10-21

Scientific Reports

Abstract:Effective antibacterial therapy while accelerating the repair of bone defects is crucial for the treatment of osteomyelitis. Inspired by the protective mechanism of Andrias davidianus , we constructed an antibacterial hydrogel scaffold with excellent rigidity and long-term slow-release activity. While retaining the toughness of the skin secretion of Andrias davidianus (SSAD), the rigidity of the hydrogel material is increased by incorporating hydroxyapatite to meet the demands of bone-defect-filling materials. It also exerted antibacterial effects via the slow-release of vancomycin from local osteomyelitis lesions. Notably, the hydrogel can also carry a high stable recombinant miR-214-3p inhibitor (MSA-anti214). By the delivery of nano vector polyvinylamine, the long-term slow-release of MSA-anti214 is achieved to promote bone repair, making this composite hydrogel a potential SSAD-based osteomyelitis alleviator (SOA). In vitro and vivo results verified that the SOA effectively eliminated Staphylococcus aureus and repaired bone defects, ultimately mitigating the progression of osteomyelitis. This composite hydrogel extends the economic application prospects of A. davidianus and has provided new insights for the treatment of osteomyelitis. The study also explored new insights for the bone filling materials of bone defection and other skeletal system diseases.

multidisciplinary sciences
Injectable gelatin microspheres for osteomyelitis treatment: osteogenic and anti-inflammatory effect

Rui Zhang,Li Chen,Yijing Stehle,Mingyue Lin,Chenxin Wang,Yufan Li,Min Huang,Yubao Li,Qin Zou

DOI: https://doi.org/10.1039/d3ma00279a

2023-01-01

Materials Advances

Abstract:Gel/n-HA composite microspheres (VM) have shown successful therapeutic results in the treatment of osteomyelitis through targeted antibacterial, inflammatory regulation, osteoblast recruitment and bone regeneration characteristics.
Injectable hydrogel as a carrier of vancomycin and a cathelicidin-derived peptide for osteomyelitis treatment

Alexandra Machado,Isabel Pereira,Vanessa Silva,Isabel Pires,Justina Prada,Patrícia Poeta,Luís Costa,José Eduardo Pereira,Miguel Gama

DOI: https://doi.org/10.1002/jbm.a.37432

Abstract:A local drug delivery system that attempts to find a suitable balance between antimicrobial and regenerative actions was developed for osteomyelitis treatment (OM). This system combines the angiogenic and immunomodulatory peptide LLKKK18 (LL18) and vancomycin hydrochloride (VH), loaded into an injectable oxidized dextrin (ODEX)-based hydrogel (HG). In vitro cytotoxicity was analyzed in MC3T3-E1 pre-osteoblasts and erythrocytes. The kinetics of LL18 release was studied. Antimicrobial activity was assessed in vitro against a clinical Methicillin-Resistant Staphylococcus aureus (MRSA) strain. A rat model of acute OM was developed by direct inoculation into a tibia defect, concomitantly with the implantation of the drug-loaded HG. The local bioburden was quantified and damage in surrounding tissues was examined histologically. In vitro, ODEX-based HG displayed a safe hemolytic profile. Half of LL18 (53%) is released during the swelling phase at physiological pH, then being gradually released until complete HG degradation. LL18-loaded HG at 300 μM was the most effective peptide formulation in decreasing in vivo infection among concentrations ranging from 86 to 429 μM. The histopathological scores observed in vivo varied with the LL18 concentration in a dose-dependent manner. VH at 28 mM completely eradicated bacteria, although with substantial tissue injury. We have found that sub-millimolar doses of VH combined with LL18 at 300 μM may suffice to eradicate the infection, with reduced tissue damage. We propose an easy-to-handle, shape-fitting HG formulation with the potential to treat MRSA-infected bone with low VH doses associated with LL18.
Thermosensitive vancomycin@PLGA-PEG-PLGA/HA hydrogel as an all-in-one treatment for osteomyelitis

Baoming Yuan,Yanfeng Zhang,Qian Wang,Guangkai Ren,Yanbing Wang,Shicheng Zhou,Qingyu Wang,Chuangang Peng,Xueliang Cheng

DOI: https://doi.org/10.1016/j.ijpharm.2022.122225

IF: 6.51

2022-11-01

International Journal of Pharmaceutics

Abstract:Osteomyelitis is a difficult-to-treat infectious disease. Treatment, which includes controlling the infection and removing necrotic tissues, is challenging. Considering the side effects and drug resistance of systemic antibiotics, local drug delivery systems are being explored. Antibiotic-loaded bone cement is the main treatment strategy; however, it has several disadvantages. Thus, based on its thermosensitive gelation properties, poly(D, L-lactide-co-glycolide)-poly(ethylene glycol)-poly(D, L-lactide-co-glycolide) (PLGA-PEG-PLGA) copolymer was used as a sustained-release drug carrier by calibrating its synthesis parameters. We prepared and characterized vancomycin@PLGA-PEG-PLGA/hydroxyapatite (HA) thermosensitive hydrogel with an LA/GA ratio of 15:1. The rheological characteristics, sol-gel phase-transition properties, and critical micelle concentration value of the PLGA-PEG-PLGA/HA complex confirmed that it undergoes a temperature-sensitive sol-gel phase transition. Furthermore, the HA in the composite increased the storage modulus of the system. FT-IR, XRD, and TEM findings showed that HA could be dispersed uniformly in the PLGA-PEG-PLGA polymer. Moreover, HA neutralized acidity during polymer degradation, improving in vitro cytocompatibility. In vitro and in vivo antibacterial experiments showed that the composite sustained-release system exhibited good bone repair characteristics owing to its efficacy in infection treatment. Therefore, vancomycin@PLGA-PEG-PLGA/HA allows sustained release of antibiotics and promotes bone tissue repair, showing potential for wide clinical applicability.

pharmacology & pharmacy
Remodeling Microenvironment for Implant‐associated Osteomyelitis by Dual Metal Peroxide

Xin Guan,Siyuan Wu,Sixue Ouyang,Shuchen Ren,Naiqian Cui,Xiaohu Wu,Dayong Xiang,Wenting Chen,Bin Yu,Peng Zhao,Bowei Wang

DOI: https://doi.org/10.1002/adhm.202303529

IF: 10

2024-03-03

Advanced Healthcare Materials

Abstract:Implant‐associated osteomyelitis (IAOM) is characterized by deep bone infection and progressive bone destruction, current therapy of long‐term high‐dose antibiotic treatment and radical surgical debridement often results in drug‐resistance and large bone defect. It is highly challenging to develop an antibiotic‐free, rapid bactericidal and osteogenic‐enhanced strategy for IAOM. Herein, we design an IAOM tailored anti‐bacterial and osteoinductive composite of Cu‐Sr peroxide nanoparticles (CSp NPs) encapulated in polyethylene glycol diacrylate (PEGDA) (CSp@PEGDA). The dual functional CSp NPs spontaneously displays in situ H2O2 self‐supplying and Fenton‐catalytic Cu2+ ions release, generating plenty of highly toxic hydroxyl radical (·OH) in a pH‐responsive manner for bacterial killing, while the released Sr2+ promotes the in vitro osteogenicity regarding cell proliferation, alkaline phosphatase activity, extracellular matrix calcification, and osteo‐associated genes expression. The integration of Cu2+ and Sr2+ in synthesized CSp NPs together with the coated PEGDA hydrogel ensures the stable and sustainable ions release during short‐ and long‐term periods. Benefitted from the injectablity and photo‐crosslinkability, CSp@PEGDA is able to thoroughly fill the infectious site and rapidly gelate in situ for bacterial elimination and bone regeneration, which is successfully verified through in vivo evaluation using a clinical‐simulating IAOM mouse model. These favorable abilities of CSp@PEGDA precisely meet the multiple therapeutic needs and pave a promising way for implant‐associated osteomyelitis treatment. This article is protected by copyright. All rights reserved

nanoscience & nanotechnology,engineering, biomedical,materials science, biomaterials
Peptide Polymer‐Doped Cement Acting as an Effective Treatment of MRSA‐Infected Chronic Osteomyelitis

Yueming Wu,Yaofa Lin,Zihao Cong,Kang Chen,Ximian Xiao,Xue Wu,Longqiang Liu,Yunrui She,Shiqi Liu,Ruiyi Zhou,Gang Yin,Xiaoyan Shao,Yidong Dai,Haodong Lin,Runhui Liu

DOI: https://doi.org/10.1002/adfm.202107942

IF: 19

2021-11-05

Advanced Functional Materials

Abstract:Chronic osteomyelitis is a painful and serious disease normally caused by infected surgical prostheses or infected fractures. Currently, antibiotic‐loaded cements are extensively used as the treatment in clinical practice. However, the quick emergence of antibiotic‐resistant bacteria has resulted in a formidable challenge in treating chronic osteomyelitis, such as the chronic osteomyelitis caused by methicillin‐resistant Staphylococcus aureus (MRSA). Aiming to address MRSA‐infected chronic osteomyelitis, an antibacterial peptide polymer doped polymethylmethacrylate bone cement pellets (PMMA@polymer) is prepared. The peptide polymer is designed as the synthetic mimic of host defense peptide and enables PMMA@polymer to have notable advantages, including complete release of antibacterial agent from PMMA, potent and robust activity against MRSA even after autoclave and enzymatic treatment, and low susceptibility to antibacterial resistance. PMMA@polymer showed potent in vitro activities against MRSA, superior in vivo therapeutic efficacy in a rabbit chronic osteomyelitis model, and low toxicity during the treatment. These advantages and the easy preparation of PMMA@polymer altogether suggest the great potential of PMMA@polymer as an effective treatment of MRSA‐infected chronic osteomyelitis. This study opens new avenues in developing antibacterial biomaterials for the treatment of chronic orthopedic infections, frequently caused by drug‐resistant bacteria. The antibacterial peptide polymer doped polymethylmethacrylate pellets (PMMA@polymer) act as an effective treatment of MRSA‐infected chronic osteomyelitis, with notable advantages, including antibiotic free, complete release of antibacterial polymer, killing drug‐resistant MRSA, low‐susceptible to antimicrobial resistance, and stable under heat and enzyme.

materials science, multidisciplinary,chemistry, physical,physics, applied, condensed matter,nanoscience & nanotechnology
Small Extracellular Vesicles Laden Oxygen-Releasing Thermosensitive Hydrogel for Enhanced Antibacterial Therapy against Anaerobe-Induced Periodontitis Alveolar Bone Defect

Leiguo Ming,Yanling Qu,Zhe Wang,Lingjuan Dong,Yinghui Li,Fen Liu,Qingxia Wang,Dan Zhang,Zhifeng Li,Zhifei Zhou,Fengqing Shang,Xiaodong Xie

DOI: https://doi.org/10.1021/acsbiomaterials.3c00493

2024-02-12

Abstract:Periodontitis is a bacterially induced chronic destructive inflammatory disease that leads to irreversible destruction of the tooth supporting structure, including connective tissue destruction, bone resorption, and even tooth loss. Until now, there has been no effective treatment to repair inflammatory bone loss in periodontitis. Recently, small extracellular vesicles (sEVs) emerged as the essential paracrine factors of mesenchymal stem cells (MSCs) that mediated tissue regeneration. However, limitations of antimicrobial activity associated with the use of sEVs have led to the urgency of new alternative strategies. Currently, we investigated the potential of a biocompatible oxygen-releasing thermosensitive hydrogel laded with sEVs secreted by bone marrow MSCs (BMMSCs) for the alveolar bone defect in periodontitis. The hydrogel composed of different polymers such as chitosan (CS), poloxamer 407 (P407), and cross-linked hyaluronic acid (c-HA) conglomerating is a kind of nanoporous structure material. Then, the gel matrix further encapsulated sEVs and calcium peroxide nanoparticles to realize the control of sEVs and oxygen release. Furthermore, ascorbic acid was added to achieve the REDOX equilibrium and acid-base equilibrium. The experiments in vivo and in vitro proved its good biocompatibility and effectively inhibited the growth of the periodontal main anaerobe, relieved periodontal pocket anaerobic infections, and promoted the periodontal defect regeneration. Therefore, this finding demonstrated that it was a promising approach for combating anaerobic pathogens with enhanced and selective properties in periodontal diseases, even in other bacteria-induced infections, for future clinical application.
Peroxynitrous-acid-induced chemiluminescence detection of nitrite based on Microfluidic chip.

Jing Wu,Xiong Wang,Yitong Lin,Yongzan Zheng,Jin‐Ming Lin

DOI: https://doi.org/10.1016/j.talanta.2016.03.062

2016-07-01

Abstract:
A Microenvironment-Responsive, Controlled Release Hydrogel Delivering Embelin to Promote Bone Repair of Periodontitis via Anti-Infection and Osteo-Immune Modulation

Guanming Cai,Lin Ren,Jiali Yu,Siqi Jiang,Gen Liu,Shujie Wu,Bin Cheng,Weichang Li,Juan Xia

DOI: https://doi.org/10.1002/advs.202403786

Abstract:Periodontitis, a prevalent chronic inflammatory disease, poses significant challenges for effective treatment due to its complex etiology involving specific bacteria and the inflammatory immune microenvironment. Here, this study presents a novel approach for the targeted treatment of periodontitis utilizing the immunomodulatory and antibacterial properties of Embelin, a plant-derived compound, within an injectable hydrogel system. The developed Carboxymethyl Chitosan-Oxidized Dextran (CMCS-OD) hydrogel formed via dynamic chemical bonds exhibited self-healing capabilities and pH-responsive behavior, thereby facilitating the controlled release of Embelin and enhancing its efficacy in a dynamic oral periodontitis microenvironment. This study demonstrates that this hydrogel system effectively prevents bacterial invasion and mitigates excessive immune response activation. Moreover, it precisely modulates macrophage M1/M2 phenotypes and suppresses inflammatory cytokine expression, thereby fostering a conducive environment for bone regeneration and addressing periodontitis-induced bone loss. These findings highlight the potential of the approach as a promising strategy for the clinical management of periodontitis-induced bone destruction.

Heuristic for Two-Level Cache Hierarchy Exploration Considering Energy Consumption and Performance

A Chitosan/gelatin/aldehyde Hyaluronic Acid Hydrogel Coating Releasing Calcium Ions and Vancomycin in Ph Response to Prevent the Formation of Bacterial Biofilm

An injectable magnesium-coordinated phosphate chitosan-based hydrogel loaded with vancomycin for antibacterial and osteogenesis in the treatment of osteomyelitis

In situ formed antibacterial hydrogel with collagenase-responsive activity for prevention of MRSA-induced osteomyelitis

Multifunctional Injectable Microspheres Containing "Naturally-Derived" Photothermal Transducer for Synergistic Physical and Chemical Treating of Acute Osteomyelitis through Sequential Immunomodulation.

Preparation of fish collagen and vancomycin microspheres based on microfluidic technology and its application in osteomyelitis

Vancomycin-loaded silk fibroin microspheres in an injectable hydrogel for chronic osteomyelitis therapy

Injectable Chitosan-Based Thermosensitive Hydrogel/Nanoparticle-Loaded System for Local Delivery of Vancomycin in the Treatment of Osteomyelitis

Injectable rBMSCs-laden hydrogel microspheres loaded with naringin for osteomyelitis treatment

Silk fibroin/chitosan thiourea hydrogel scaffold with vancomycin and quercetin-loaded PLGA nanoparticles for treating chronic MRSA osteomyelitis in rats

An injectable carboxymethyl chitosan hydrogel scaffold formed via coordination bond for antibacterial and osteogenesis in osteomyelitis

What can RSS point out in accounts receivable?

An Andrias davidianus derived composite hydrogel with enhanced antibacterial and bone repair properties for osteomyelitis treatment

Injectable gelatin microspheres for osteomyelitis treatment: osteogenic and anti-inflammatory effect

Injectable hydrogel as a carrier of vancomycin and a cathelicidin-derived peptide for osteomyelitis treatment

Thermosensitive vancomycin@PLGA-PEG-PLGA/HA hydrogel as an all-in-one treatment for osteomyelitis

Remodeling Microenvironment for Implant‐associated Osteomyelitis by Dual Metal Peroxide

Peptide Polymer‐Doped Cement Acting as an Effective Treatment of MRSA‐Infected Chronic Osteomyelitis

Small Extracellular Vesicles Laden Oxygen-Releasing Thermosensitive Hydrogel for Enhanced Antibacterial Therapy against Anaerobe-Induced Periodontitis Alveolar Bone Defect

Peroxynitrous-acid-induced chemiluminescence detection of nitrite based on Microfluidic chip.

A Microenvironment-Responsive, Controlled Release Hydrogel Delivering Embelin to Promote Bone Repair of Periodontitis via Anti-Infection and Osteo-Immune Modulation